Probiotical S.P.A.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Jun 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 20, 2026The maintenance fee for Composition for Use in the Treatment And/Or Improvement of Sleep and Mood Disorders (US 11,679,135) comes due Dec 20, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due May 17, 2027The maintenance fee for Bacteriocin-producing Lactobacillus pentosus and the use thereof in food and pharmaceutical compositions (US 9,185,927) comes due May 17, 2027. Unpaid by Nov 17, 2027, it lapses early.
- 1 fee due Jul 12, 2027The maintenance fee for Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality (US 9,233,130) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
- 1 fee due Aug 9, 2027The maintenance fee for Use of lactobacilli inhibiting gas producing coliform bacterial isolated from infants affected by colic (US 9,255,246) comes due Aug 9, 2027. Unpaid by Feb 9, 2028, it lapses early.
- 1 fee due Oct 30, 2027The maintenance fee for Composition for use in the treatment of major depressive disorder (US 11,969,449) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,255,246 | Use of lactobacilli inhibiting gas producing coliform bacterial isolated from infants affected by colic In force · From the USPTO record | In force | From the USPTO record | |
| US 9,233,130 | Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality In force · From the USPTO record | In force | From the USPTO record | |
| US 9,185,927 | Bacteriocin-producing Lactobacillus pentosus and the use thereof in food and pharmaceutical compositions In force · From the USPTO record | In force | From the USPTO record | |
| US 8,734,783 | Composition comprising probiotic bacteria for use in the treatment of immune disorders In force · From the USPTO record | In force | From the USPTO record | |
| US 9,498,503 | Composition comprising probiotic bacteria for use in the treatment of immune disorders In force · From the USPTO record | In force | From the USPTO record | |
| US 9,931,363 | Composition comprising probiotic bacteria for use in the treatment of immune disorders In force · From the USPTO record | In force | From the USPTO record | |
| US 9,492,377 | Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections In force · From the USPTO record | In force | From the USPTO record | |
| US 11,110,135 | Bacterial strains belonging to the genus Bifidobacterium for use in the treatment of hypercholesterolaemia In force · From the USPTO record | In force | From the USPTO record | |
| US 11,446,340 | Probiotic bacterial strains and symbiotic composition containing the same intended for infant food In force · From the USPTO record | In force | From the USPTO record | |
| US 10,286,017 | Probiotic Bacterial Strains and Symbiotic Composition Containing the Same Intended for Infant Food In force · High confidence | In force | High confidence |
Also on record, not counted in the 25: 7 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 3 abandoned · 26 no status recorded